Plain-English translation of NCT07092566 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a combination of four medications called R.E.C.K. (ropivacaine, , clonidine, and ) works better than a long-acting numbing medication called at controlling pain after robotic kidney cancer surgery. Both treatments are given during surgery, and researchers will track how much pain you have and how many pain medications you need after you go home.
After kidney surgery, many patients struggle with pain and need strong opioid medications to feel better. This trial is exploring whether this medication combination might provide better pain control with fewer opioids, helping patients recover more comfortably.
You likely qualify if…
You likely don't qualify if…
You will receive one of the two pain-relief treatments during your robotic kidney surgery. After surgery, you'll report your pain levels and any medications you take while you're in the hospital. Once you go home, you'll keep a simple paper diary for several days, noting your pain level and any pain medications you use. The study team will review your hospital records to see how much medication you needed during and after surgery.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States